Overview

Pharmacokinetics of Ceftaroline in Subjects 12 to 17 Years of Age

Status:
Completed
Trial end date:
2009-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the pharmacokinetics of ceftaroline in pediatric subjects
Phase:
Phase 1
Details
Lead Sponsor:
Forest Laboratories
Treatments:
Ceftaroline fosamil
Cephalosporins